HealthQuill Ovaries
Britain’s Competition and Markets Authority (CMA) expressed concerns over Theramex's planned acquisition of Femoston and Duphaston stating it may reduce competition and choice for hormone replacement therapy (HRT) treatments in the country.
Drugs Health Medical

Ovary removal at younger age can lead to cognitive decline

HQ Team June 27, 2024: A new study has  found that the removal of both ovaries can have long-term health consequences The US.

Read More